JI TAI

Welcome to the Brand page for “JI TAI”, which is offered here for Pharmaceutical preparations for target delivery of small molecules, rna and gene therapies for central nervous system diseases, liver diseases, lung diseases, cancer, immune system diseases, rare diseases caused by genetic anomalies, kidney diseases, gastrointestinal diseases, and infectious diseases; drug delivery agents in the form of lipid nanoparticles, solid dispersion solutions, gel, self-emulsifying subcutaneous injections, and sustained and controlled release formulations that facilitate the delivery of pharmaceutical preparations and improve the patients' medication experience;the wording ji tai has no meaning in a foreign language.;pharmaceutical research and development services;.

Its status is currently believed to be active. Its class is unavailable. “JI TAI” is believed to be currently owned by “METIS THERAPEUTICS INC.”

Owner:
METIS THERAPEUTICS INC.
Owner Details
Description:
Pharmaceutical preparations for target delivery of small molecules, RNA and gene therapies for central nervous system diseases, liver diseases, lung diseases, cancer, immune system diseases, rare diseases caused by genetic anomalies, kidney diseases, gastrointestinal diseases, and infectious diseases; drug delivery agents in the form of lipid nanoparticles, solid dispersion solutions, gel, self-emulsifying subcutaneous injections, and sustained and controlled release formulations that facilitate the delivery of pharmaceutical preparations and improve the patients' medication experience;The wording JI TAI has no meaning in a foreign language.;pharmaceutical research and development services;
Categories: PHARMACEUTICAL PREPARATIONS TARGET DELIVERY